4-[[2-[[4-chloro-3-(trifluoromethyl)phenyl]amino]-3H-benzimidazol-5-yl]oxy]-N-methyl-pyridine-2-carboxamide

This compound is a synthetic small molecule with the chemical formula C21H15ClF3N5O2 and a molecular weight of approximately 461.8 g/mol. It belongs to the class of diarylethers and features a benzimidazole core linked to a pyridine carboxamide moiety via an ether bond, with additional chloro and trifluoromethyl substitutions on the phenyl ring. The compound is listed in chemical databases such as PubChem (CID: 11167118), DrugBank (DB06938), ChEMBL (CHEMBL394826), and ChemSpider (9342214). While it has been cataloged as an experimental or research molecule, there is no evidence that it has reached clinical development or approval for any therapeutic indication. Its mechanism of action, biological targets, pharmacological activity, developer(s), or manufacturer(s) are not specified in available public resources[1][3][5]. No information suggests it is marketed under any brand name.

Other names

4-[2-(4-Chloro-3-trifluoromethylphenylamino)-1H-benzimidazol-5-yloxy]-pyridine-2-carboxylic acid methylamide4-[[(2-{[4-chloro–3-(trifluoromethyl)phenyl]amino}-1H–1,3-benzodiazol–6–yl)oxy]]–N-methylpyridine–2-carboxamide